Display options
Share it on

Expert Rev Proteomics. 2021 Jan;18(1):27-48. doi: 10.1080/14789450.2021.1886929. Epub 2021 Mar 07.

Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases.

Expert review of proteomics

Nicole Campese, Giovanni Palermo, Claudia Del Gamba, Maria Francesca Beatino, Alessandro Galgani, Elisabetta Belli, Eleonora Del Prete, Alessandra Della Vecchia, Andrea Vergallo, Gabriele Siciliano, Roberto Ceravolo, Harald Hampel, Filippo Baldacci

Affiliations

  1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  2. GRC N° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard De L'hôpital, Sorbonne University, Paris, France.

PMID: 33545008 DOI: 10.1080/14789450.2021.1886929

[No abstract available.]

Keywords: Alzheimer’s disease; fluid biomarkers; neurodegenerative diseases; tau; tau-PET; ultrasensitive techniques

Publication Types